Tokyo, Nov. 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059672) titled 'a study on patient profiles of obesity patients with semaglutide' on Nov. 6.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - HEC Science Clinic
Condition:
Condition - obesity patiennts
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to investigate the patient background in which semaglutide administration is effective for patients with obesity, as well as to examine the involvement of dietitians in the care of patients with obesity.
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - Semaglutide injection
Eligibility:
Age-lower limit - 18
years-old
BMI is 27 kg/m2 or higher and has two or more obesity-related health issues
> BMI is 35 kg/m2 or higher
Key exclusion criteria - 1.Individuals who do not consent to participate in the study
2.Those whom the principal investigator or co-investigator determines are not suitable to participate in this clinical research
3.Women who are pregnant or may be pregnant
Target Size - 60
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 04 Month 09 Day
Date of IRB - 2025 Year 04 Month 09 Day
Anticipated trial start date - 2025 Year 07 Month 01 Day
Last follow-up date - 2029 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066512
Disclaimer: Curated by HT Syndication.
